Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for AMLOGENYX with the United States Patent and Trademark Office. The USPTO has given the AMLOGENYX trademark a serial number of 98745195. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 11, 2024. This trademark is owned by Amlogenyx Inc.. The AMLOGENYX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of neurological and genetic diseases and disorders; chemical, biological, and biochemical preparations for use in gene delivery technology for medical use, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for use in in vivo therapeutic use in gene therapy